Tag: Series
Light Horse Therapeutics Raises $62M in Series A Financing
Light Horse Therapeutics, a San Diego, CA-based developer of small molecule therapeutics, raised $62M in Sequence A funding.…
Ouro Medicines Raises $120M in Series A Funding
Ouro Medicines, a San Francisco, CA-based biotechnology firm creating immune reset therapeutics for folks residing with power immune-mediated…
Air Raises $35M in Series B Funding
Air, a NYC-based supplier of a purpose-built platform for inventive operations, raised $35M in Sequence B funding. The…
A2 Biotherapeutics Raises $80M Series C Funding
A2 Biotherapeutics, an Agoura Hills, CA-based clinical-stage cell remedy firm creating logic-gated cell therapies to selectively goal tumor…
Innovaccer Raises $275M in Series F Funding
Innovaccer Inc., a San Francisco, CA-based healthcare AI firm, raised $275M in Sequence F funding spherical. The spherical…
RLTYco Raises $20M Series A Funding
RLTYco, a NYC-based supplier of complete sources for actual property professionals, raised $20M in Collection A funding. The…
Oxford Cancer Analytics Raises USD$11M in Series A Funding
Oxford Cancer Analytics, an Oxford, UK- and Toronto, Canada-based medtech firm creating blood assessments for early most cancers…
Gridware Raises $26.4M in Series A Funding
Gridware, a San Francisco, CA-based steady energy grid monitoring answer supplier, raised $26.4M in Sequence A funding. The…
Neumirna Therapeutics Raises €20M in Series A Funding
Neumirna Therapeutics, a Copenhagen, Denmark-based RNA-focused biotech firm, raised €20M in Collection A funding. The spherical was led…
Frontier Direct Care Holds Initial Closing of $20M Series B Financing
Frontier Direct Care, a Harlingen, TX-based employer-funded healthcare firm, raised $20M in Collection B funding. The spherical was…
Alesta Therapeutics Raises €65M in Series A Funding
Alesta Therapeutics, a Leiden, the Netherlands-based biotechnology firm targeted on growing transformative small molecule therapies for uncommon ailments,…
Aviceda Therapeutics Raises Upsized $207.5M in Series C Financing
Aviceda Therapeutics, a Cambridge, MA-based non-public, clinical-stage biotech firm centered on growing new immunomodulators, raised $207.5M in Collection…